Glaukos
At a glance
Glaukos reported 2025 revenue of $507.4M, up 32.3% from $383.5M in 2024. Over 4 years since 2021 ($294M), that is growth of about 14.6% a year. Operating margin was -39.3%, down from -11.2% in 2021. 2025 was the highest revenue year in this period. The company posted a loss in 2021, 2022, 2023, 2024 and 2025.
In the last 12 months 8 insiders reported 0 open-market purchases and 31 sales ($69.3M). 19 of the sales were made under pre-arranged 10b5-1 plans. The largest was a sale of $31.6M by CHAIRMAN & CEO Thomas William Burns on Jan 20, 2026.
Glaukos filed 10 current reports (Form 8-K) in the last 12 months, most often for results of operations (5), regulation fd disclosure (4) and shareholder vote results (1).
2 of the 20 investors tracked here held Glaukos at the last quarter end, worth $21M combined. It is the largest weight for Renaissance Technologies (0% of its portfolio), followed by Bridgewater Associates (0%). New this quarter: Bridgewater Associates. Added: Renaissance Technologies.
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | -$49.6M | -$99.2M | -$134.7M | -$146.4M | -$187.7M |
| Diluted EPS | $-1.07 | $-2.09 | $-2.78 | $-2.77 | $-3.28 |
Fiscal year ends Dec 31 · incorporated in DE
Tracked investors holding (13F)
Weight is the share of each investor's portfolio, as of the quarter end.
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined